High-Risk HPV Testing in Head and Neck Carcinoma: Key Updates from the 2025 College of American Pathologists Guideline.

Saved in:
Bibliographic Details
Title: High-Risk HPV Testing in Head and Neck Carcinoma: Key Updates from the 2025 College of American Pathologists Guideline.
Authors: Faquin WC; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, WRN 219, Boston, MA, 02114, USA. Wfaquin@mgh.harvard.edu., Lewis JS Jr; Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Beadle B; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA., Bishop JA; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA., Chernock RD; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Krane JF; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Moncur JT; Office of the Director, The Joint Pathology Center, Silver Springs, MD, USA., Rocco JW; Department of Otolaryngology- Head and Neck Surgery, Ohio State University Wexner Medical Center, Columbus, OH, USA., Schwartz MR; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA., Seethala RR; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Source: Head and neck pathology [Head Neck Pathol] 2025 Sep 29; Vol. 19 (1), pp. 115. Date of Electronic Publication: 2025 Sep 29.
Publication Type: Journal Article; Review; Practice Guideline
Journal Info: Publisher: Springer Science+ Business Media Country of Publication: United States NLM ID: 101304010 Publication Model: Electronic Cited Medium: Internet ISSN: 1936-0568 (Electronic) Linking ISSN: 1936055X NLM ISO Abbreviation: Head Neck Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1936-0568
DOI:10.1007/s12105-025-01847-2